Vaccine-breakthrough infection by the SARS-CoV-2 omicron variant elicits broadly cross-reactive immune responses.
Zhou R, To KK, Peng Q, Chan JM, Huang H, Yang D, Lam BH, Chuang VW, Cai JP, Liu N, Au KK, Tsang OT, Yuen KY, Chen Z.
Zhou R, et al. Among authors: cai jp.
Clin Transl Med. 2022 Jan;12(1):e720. doi: 10.1002/ctm2.720.
Clin Transl Med. 2022.
PMID: 35083867
Free PMC article.
No abstract available.